Literature DB >> 31774958

Essential Thrombocythemia.

Ayalew Tefferi1, Animesh Pardanani1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31774958     DOI: 10.1056/NEJMcp1816082

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  21 in total

Review 1.  Novel and combination therapies for polycythemia vera and essential thrombocythemia: the dawn of a new era.

Authors:  Jan Philipp Bewersdorf; Amer M Zeidan
Journal:  Expert Rev Hematol       Date:  2020-11-01       Impact factor: 2.929

2.  Essential thrombocythemia complicated with simultaneous two-vessel acute myocardial infarction in the subacute phase of takotsubo cardiomyopathy: A case report.

Authors:  Yusuke Yamazaki; Yohei Numasawa; Taro Mase; Takashi Maeda; Yuhei Shinoda; Kosuke Watabe; Shoya Ono; Ayami Naito; Souichi Yokokura; Sho Haginiwa; Hidenori Kojima; Makoto Tanaka
Journal:  J Cardiol Cases       Date:  2022-07-15

3.  Late excess mortality in essential thrombocythemia: a population-based study in the Netherlands, 2001-2018.

Authors:  Tom S M Posthuma; Otto Visser; Peter A W Te Boekhorst; Avinash G Dinmohamed
Journal:  Leukemia       Date:  2021-08-06       Impact factor: 11.528

4.  Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19.

Authors:  Sokratis A Apostolidis; Amrita Sarkar; Heather M Giannini; Rishi R Goel; Divij Mathew; Aae Suzuki; Amy E Baxter; Allison R Greenplate; Cécile Alanio; Mohamed Abdel-Hakeem; Derek A Oldridge; Josephine Giles; Jennifer E Wu; Zeyu Chen; Yinghui Jane Huang; Ajinkya Pattekar; Sasikanth Manne; Oliva Kuthuru; Jeanette Dougherty; Brittany Weiderhold; Ariel R Weisman; Caroline A G Ittner; Sigrid Gouma; Debora Dunbar; Ian Frank; Alexander C Huang; Laura A Vella; John P Reilly; Scott E Hensley; Lubica Rauova; Liang Zhao; Nuala J Meyer; Mortimer Poncz; Charles S Abrams; E John Wherry
Journal:  bioRxiv       Date:  2021-05-03

5.  Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study.

Authors:  Yoshinori Hashimoto; Tomoki Ito; Akihiko Gotoh; Mika Nakamae; Fumihiko Kimura; Michiaki Koike; Keita Kirito; Hideho Wada; Kensuke Usuki; Takayuki Tanaka; Takehiko Mori; Satoshi Wakita; Toshiki I Saito; Akiko Kada; Akiko M Saito; Kazuya Shimoda; Yuka Sugimoto; Toshiro Kurokawa; Akihiro Tomita; Yoko Edahiro; Koichi Akashi; Itaru Matsumura; Katsuto Takenaka; Norio Komatsu
Journal:  Int J Hematol       Date:  2021-11-02       Impact factor: 2.490

6.  Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.

Authors:  Alberto Tosetto; Bianca Rocca; Giovanna Petrucci; Silvia Betti; Denise Soldati; Elena Rossi; Andrea Timillero; Viviana Cavalca; Benedetta Porro; Alessandra Iurlo; Daniele Cattaneo; Cristina Bucelli; Alfredo Dragani; Mauro Di Ianni; Paola Ranalli; Francesca Palandri; Nicola Vianelli; Eloise Beggiato; Giuseppe Lanzarone; Marco Ruggeri; Giuseppe Carli; Elena Maria Elli; Stefania Priolo; Maria Luigia Randi; Irene Bertozzi; Giuseppe Gaetano Loscocco; Alessandra Ricco; Giorgina Specchia; Alessandro Maria Vannucchi; Francesco Rodeghiero; Valerio De Stefano; Carlo Patrono
Journal:  Clin Pharmacol Ther       Date:  2021-11-20       Impact factor: 6.903

7.  Cerebrovascular manifestations in hematological diseases: an update.

Authors:  José M Ferro; Joana Infante
Journal:  J Neurol       Date:  2021-02-13       Impact factor: 4.849

8.  Alterations of Signaling Pathways in Essential Thrombocythemia with Calreticulin Mutation.

Authors:  Wuhan Hui; Wei Zhang; Congyan Liu; Suigui Wan; Wanling Sun; Li Su
Journal:  Cancer Manag Res       Date:  2021-08-07       Impact factor: 3.989

9.  Complex intracranial vascular complications caused by essential thrombocythemia: a critical case report.

Authors:  Jian Xie; Leiyu Geng; Baoyu Yuan; Yijing Guo; Zhijun Zhang
Journal:  BMC Neurol       Date:  2020-11-07       Impact factor: 2.474

10.  Identification of Potential Key Genes and Regulatory Markers in Essential Thrombocythemia Through Integrated Bioinformatics Analysis and Clinical Validation.

Authors:  Jie Wang; Yun Wu; Md Nazim Uddin; Rong Chen; Jian-Ping Hao
Journal:  Pharmgenomics Pers Med       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.